G Galindo

486 total citations
8 papers, 428 citations indexed

About

G Galindo is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G Galindo has authored 8 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G Galindo's work include Receptor Mechanisms and Signaling (4 papers), Renin-Angiotensin System Studies (3 papers) and Ion Transport and Channel Regulation (2 papers). G Galindo is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Renin-Angiotensin System Studies (3 papers) and Ion Transport and Channel Regulation (2 papers). G Galindo collaborates with scholars based in France. G Galindo's co-authors include C Lacour, Catherine Cazaubon, Alain Roccon, Jean Gougat, Gérard Barthélémy, P. Guiraudou, Bruno Gautret, Dino Nisato, Claude Barberis and Corinne Garcia and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

G Galindo

8 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Galindo France 5 208 174 154 128 78 8 428
P. Guiraudou France 5 225 1.1× 193 1.1× 117 0.8× 195 1.5× 73 0.9× 9 554
Masashi Aoyama Japan 8 312 1.5× 57 0.3× 239 1.6× 99 0.8× 58 0.7× 9 586
Michael Shalmi Denmark 13 224 1.1× 45 0.3× 141 0.9× 27 0.2× 133 1.7× 39 530
E J Stack United States 14 278 1.3× 129 0.7× 49 0.3× 37 0.3× 111 1.4× 18 589
H.J.G. Hollemans Netherlands 7 90 0.4× 79 0.5× 97 0.6× 50 0.4× 51 0.7× 11 430
Masahiro Takanashi Japan 14 452 2.2× 369 2.1× 144 0.9× 93 0.7× 79 1.0× 29 756
Lori R. Kisley United States 9 145 0.7× 64 0.4× 27 0.2× 39 0.3× 91 1.2× 11 415
Robert E. Beach United States 11 228 1.1× 81 0.5× 61 0.4× 13 0.1× 97 1.2× 18 425
George S. Denning United States 4 172 0.8× 229 1.3× 49 0.3× 35 0.3× 93 1.2× 6 397
A. Marquez-Julio Canada 10 205 1.0× 317 1.8× 34 0.2× 29 0.2× 123 1.6× 14 583

Countries citing papers authored by G Galindo

Since Specialization
Citations

This map shows the geographic impact of G Galindo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Galindo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Galindo more than expected).

Fields of papers citing papers by G Galindo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Galindo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Galindo. The network helps show where G Galindo may publish in the future.

Co-authorship network of co-authors of G Galindo

This figure shows the co-authorship network connecting the top 25 collaborators of G Galindo. A scholar is included among the top collaborators of G Galindo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Galindo. G Galindo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lacour, C, Alain Roccon, G Galindo, et al.. (2004). Effects of differential blockade of the renin‐angiotensin system in postinfarcted rats. Fundamental and Clinical Pharmacology. 18(3). 299–307. 3 indexed citations
2.
Lacour, C, G Galindo, Catherine Cazaubon, et al.. (2000). Aquaretic and hormonal effects of a vasopressin V2 receptor antagonist after acute and long-term treatment in rats. European Journal of Pharmacology. 394(1). 131–138. 12 indexed citations
3.
Gal, C. Serradeil‐Le, C Lacour, G Valette, et al.. (1996). Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.. Journal of Clinical Investigation. 98(12). 2729–2738. 210 indexed citations
4.
Lacour, C, et al.. (1994). Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models. European Journal of Pharmacology. 264(3). 307–316. 22 indexed citations
5.
Blanc, Pierre, et al.. (1994). [Gastric metastasis complicating the course of lobular adenocarcinoma of the breast in a male patient].. PubMed. 23(33). 1539–1539. 1 indexed citations
6.
Cazaubon, Catherine, Jean Gougat, P. Guiraudou, et al.. (1993). Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 265(2). 826–834. 174 indexed citations
7.
Lacour, C, et al.. (1990). [Hypotensive effect of a new calcium antagonist, SR 33557 in conscious rats].. PubMed. 83(8). 1281–4. 2 indexed citations
8.
Galindo, G, et al.. (1987). Hemodynamic Response to SR 42128A in Normal and Sodium-Depleted Baboons. Journal of Cardiovascular Pharmacology. 10. 99–101. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026